US Patent 7642241 Methods of enhancing functioning of the large intestine

Patent 7642241 was granted and assigned to Nps Pharmaceuticals on January, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Nps Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76422410

Patent Inventor Names

Daniel J. Drucker0

Date of Patent

January 5, 2010

Patent Application Number

116546680

Date Filed

January 18, 2007

Patent Primary Examiner

‌

Chih-Min Kam

Patent abstract

The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases.